1. Home
  2. PECE vs EQ Comparison

PECE vs EQ Comparison

Compare PECE & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PECE

Peace Acquisition Corp Ordinary Shares

SELL

Current Price

$10.07

Market Cap

84.6M

Sector

Finance

ML Signal

SELL

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.12

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PECE
EQ
Founded
2025
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
89.4M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
PECE
EQ
Price
$10.07
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.56
AVG Volume (30 Days)
53.6K
★ 277.8K
Earning Date
N/A
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.88
$1.11
52 Week High
$10.07
$6.20

Technical Indicators

Market Signals
Indicator
PECE
EQ
Relative Strength Index (RSI) 68.09 34.08
Support Level $9.98 N/A
Resistance Level $10.07 $1.54
Average True Range (ATR) 0.01 0.13
MACD 0.00 -0.02
Stochastic Oscillator 80.00 11.30

Price Performance

Historical Comparison
PECE
EQ

About PECE Peace Acquisition Corp Ordinary Shares

Peace Acquisition Corp is a blank check company.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: